Tag: Classification

According to the World Health Organization, tuberculosis (TB) remains a major global health challenge, making effective treatment combinations essential. The classification of Rifinah is as a first-line **antituberculosis combination** therapy, consisting of two potent antibiotics, rifampicin and isoniazid. This fixed-dose combination is crucial for combating the bacteria that cause TB.

The macrolide class of antibiotics, first pioneered with the discovery of erythromycin in the 1950s, comprises a diverse range of drugs used to treat various bacterial infections. Understanding **how are macrolides classified** is key to appreciating the differences in their spectrum of activity, pharmacological properties, and clinical applications.